Steatotic livers are more susceptible to ischemia/reperfusion injury, and increase the risk of primary graft non-function after liver transplantation. The protective effects of berberine have been described in various liver pathological models. However, it is unknown if berberine exerts its beneficial action in steatotic donors undergoing liver transplantation. In the present study, male Wistar rats were fed with high-fat diet (HFD) for 12 weeks to induce moderate steatotic liver. Then orthotropic liver transplantation was constructed. Berberine (200 mg/kg/d) was given intragastrically one week before liver transplantation. Thapsigargin (TG) (0.2 mg/kg) was administrated intravenously 24 h before liver transplantation. Liver function, oxidative stress, and inflammatory cytokine were detected by biochemical or histopathological analysis. The morphology of autophagosomes and endoplasmic reticulum (ER) was observed by transmission electron microscopy. The expression of CHOP, BIP, the phosphorylation of PERK, LC3-II/I, Beclin-1, and p62 were determined by Western blot assay. The co-localization of endoplasmic reticulum marker (KDEL) and autophagic protein (LC3B) was analyzed by immunofluorescence microscopy. The level of reticulophagy hallmark (FAM134B) was determined by immunohistochemistry. Compared with HFD þ LT group, berberine ameliorated hepatocellular damage, decreased the oxidative stress level and inflammatory cytokine release. Simultaneously, berberine inhibited the expression of both endoplasmic reticulum stress parameters and autophagy-related proteins. Additionally, the co-localization of endoplasmic reticulum marker and LC3B was also reduced in HFD þ BBR þ LT group. berberine downregulated the level of FAM134B. TG reversed the beneficial effects of berberine. Our study revealed that berberine exerts protective effects on steatotic livers undergoing transplantation by inhibiting endoplasmic reticulum stress-mediated reticulophagy.
Introduction
Owing to the mismatch between organ donation and the demand for liver transplantation, expanding the liver donor pool is of vital importance. Among the common types of organs from extended-criteria donors, the potential use of steatotic livers has become a major focus of investigation for transplantation. 1, 2 Unfortunately, more than half of livers are considered as not suitable for transplantation and will be discarded due to the presence of severe fatty infiltration. Steatotic livers are more susceptible to ischemia/reperfusion (I/R) injury, which may lead to the high
Impact statement
Berberine is isolated from traditional Chinese medicine plants and has dramatically therapeutic potential against inflammation, diarrhea, and diabetes. But the benefits of BBR on steatotic grafts after liver transplantation remain poorly understood. Our findings might help explain the mechanism of berberine in protecting steatotic livers undergoing transplantation and give advantageous insights that berberine has potential as a suitable candidate for preventing hepatic injury after steatotic liver transplantation by inhibiting ER stressmediated reticulophagy.
risk of primary graft non-function after liver transplantation. 3 Some medicine has been proven effective in animal studies but none of them has been applicated in clinical liver transplantation. 4, 5 Endoplasmic reticulum (ER) is an important organelle responsible for protein synthesis and assemblage. Under pathological conditions, unfolded protein response (UPR) would be activated by sustained accumulation of misfolded or unfolded proteins in the lumen of ER, that is, ER stress. Numerous reports have suggested that ER stress is critical in the pathophysiological development of various diseases. [6] [7] [8] [9] In steatotic livers, ER stress has been implicated as a major contributor of post-transplant injury. 10 But the exact down-stream mechanism involved in the steatotic allograft injury remains unknown and need to be further investigated.
Autophagy is a critical process responsible for maintaining intracellular homeostasis by disassembling the detrimental cytoplasmic parts. 11 However, uncontrolled activation of autophagy may lead to irreversible cell damage. 12 Recent data indicate the crosstalk between ER stress and autophagy. 13 The distention of membrane from ER or Glogi complex is the beginning of autophagy initiation, which, in turn, is helpful for degrading misfolded proteins in ER. In aging adipose tissue, compromised autophagy was linked to the increase of ER stress and subsequent inflammation. 14 Guo et al. 15 found that ER stress-triggered autophagy was involved in cocaine-related neuroinflammation. However, the relationship between ER stress and autophagy has not been fully clarified.
Berberine (BBR) is a compound derived from the traditional Chinese medicine plants and has dramatically therapeutic potential against inflammation, diarrhea and so on. 16, 17 Clinical evidence suggested that BBR was a fantastic cholesterol-lowering drug with its unique mechanism different from statins. 18 A large body of experimental data has supported the notion that BBR preconditioning attenuates I/R injury of various organs including kidney, heart, and intestine. [19] [20] [21] Our previous study found that BBR mediated the protection of non-steatotic donors undergoing liver transplantation by activating Sirt1/FoxO3a signaling pathway. 22 But there is limited information available in identifying the action of BBR in steatotic livers undergoing liver transplantation.
Taken together, our present study was aimed to evaluate the beneficial effect of BBR on steatotic donor of rats after liver transplantation and explore the underlying molecular mechanisms in BBR-offered protection.
Materials and methods

Animals
All animal experiments were approved by the Committee on the Ethics of Animal Experiments of Tianjin Medical University. Male Wistar rats (six weeks) were obtained from the Military Medical Science Academy Laboratory, Beijing, China. Animals were kept four each cage and raised in a temperature-controlled environment with 12-h light/dark cycle. Rats were fed with high-fat diet (HFD) or standard diet (SD) for 12 weeks to induce steatotic or nonsteatotic liver. HFD rats would show moderate fatty infiltration in hepatocytes (40-60% steatosis). The ingredients of HFD were documented in Supplementary Table 1 .
Experimental design
Rats were randomly assigned into the following nine groups (n ¼ 6): Group 1. SD. Rats with non-steatotic livers were subjected to transverse laparotomy. Group 2. SD þ BBR. Rats with non-steatotic livers were administrated with BBR (200 mg/kg/day) intragastrically for one week before the transverse laparotomy. The optimization of BBR treatment dosage was seen in Supplementary  Figure 1 .
Group 3. SD þ LT. Rats underwent liver transplantation using non-steatotic donors.
Group 4. SD þ BBR þ LT. Rats with non-steatotic livers were administrated with BBR (200 mg/kg/day) intragastrically for one week before liver transplantation as donors.
Group 5. HFD. Rats with steatotic livers were subjected to transverse laparotomy. Group 6. HFD þ BBR. Rats with steatotic livers were administrated with BBR (200 mg/kg/day) intragastrically for one week before the transverse laparotomy. Group 7. HFD þ LT. Rats underwent liver transplantation using steatotic donors. Group 8. HFD þ BBR þ LT. Rats with steatotic livers were administrated with BBR (200 mg/kg/day) intragastrically for one week before liver transplantation as donors.
Group 9. HFD þ BBR þ TG þ LT. Rats with steatotic livers were administrated with BBR intragastrically (200 mg/kg/day, one week) and thapsigargin (TG, 0.2 mg/kg, intravenously 24 h before operation) before liver transplantation as donors. A flow-chart of experimental design is shown in Figure 1 . Figure 1 . Illustration of the experimental design. Animals were randomly assigned into the following nine groups (n ¼ 6). The rats were fed with standard diet (SD) or high-fat diet (HFD) for 12 weeks. BBR was intragastrically given at a dose of 200 mg/kg/day for one week. Liver transplantation was undergone after given BBR. Thapsigargin (TG) was intravenously given at a dose of 0.2 mg/kg for 24 h before operation. 
Establishment of rat liver transplantation model
The rat liver transplantation model was conducted without hepatic artery reconstruction according to the report from Kamada et al. 23 The rats were anesthetized by intraperitoneal injection of phenobarbitone. Donor liver was harvested in a standardized process including freeing ligaments, ligating blood vessels, cannulating common bile duct and perfusing with heparinized normal saline. Then liver donors were excised and placed in 4 C normal saline before transplantation. Recipient hepatectomy was performed and donor liver was implanted by suturing supra-hepatic and sub-hepatic vena cava, connecting cuffs with the related vessels and inserting the stent of bile duct. During the surgery, the average time for operation was 132 AE 27 min and anhepatic phase (from vena porta clamping to graft re-perfusion) was 15 AE 3 min. 24 Tissue collections and blood were collected 6 h after reperfusion.
Determination of hepatic function
The blood (3 mL) was collected from hepatic inferior cava vena and centrifugated at 3000 r/min for 20 min. Serum was measured using an automated Biochemical Analyzer (AU5400, Beckman Coulter) was used to determine the level of alanine aminotransferase (ALT) and aspartate aminotransferase (AST).
Assessing oxidative stress and inflammation parameters
Liver tissues were homogenized in phosphate buffer saline (PBS) and centrifugated at 14,000 r/min for 20 min (4 C). The supernatants were collected for detecting the concentrations of malondialdehyde (MDA), superoxide dismutase (SOD), TNF-a, and IL-b by commercially assay kits.
Histopathologic examination
Liver tissues were fixed with 10% formalin dehydrated and embedded in paraffin. The sections were dewaxed, hydrated, and stained with hematoxylin-eosin (HE) according to standard protocols. Then the slides were observed under optical light microscope. Histopathologic change of each sample was evaluated by the same pathologist in a blinded study. Hepatic damage was scored as described by Suzuki et al. 25 (Table 1) .
Transmission electron microscopy
Liver samples were fixed in 2.5% glutaraldehyde overnight and washed with PBS for three times. Then tissues were dehydrated, embedded, fixed in 10% buffered glutaraldehyde and 1% osmic acid, and finally sliced. The ultrastructure of autophagosome and ER was observed under a transmission electron microscope.
Immunofluorescence
Liver samples were incubated with anti-LC3B (1:1000, Abcam) and anti-KDEL (1:100, Abcam) overnight at 4 C followed by fluorescence secondary antibodies, anti-rabbit Alexa 568 (1:300, CST), and anti-mouse Alexa 488 (1:300, CST). The slides were counterstained with nuclear dye 4 0 ,6diamidino-2-phenylindole (DAPI) 10 min before examined under the fluorescence microscopy.
Immunohistochemistry
Liver specimens were fixed and embedded in paraffin. After dewaxing and hydration, endogenous peroxidase activity was quenched by 3% hydrogen peroxide for 15 min. Then sections were blocked with 5% normal goat serum for 20 min. The slices were incubated with primary antibody (anti-FAM134B, 1:1000) overnight. After washing, the slices were incubated with secondary antibody at room temperature for 15 min. Sections were stained with DAB kits. The FAM134B-positive cells with brown particles were counted in at least 10 different images.
Western blotting
Equal amounts of protein lysates (50 lg) were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis and transferred to PVDF membranes. Membranes were blocked in 5% skim milk for 1.5 h at room temperature and incubated at 4 C overnight with primary antibodies against PERK, p-PERK, CHOP, LC3II/LC3I, Beclin-1, p62, and GAPDH. Then membranes were incubated with horseradish peroxidase-conjugated secondary antibody (1:2000, Abcam) for 1 h and visualized with enhanced chemiluminescence reagents (Millipore, MA, USA).
Statistical analysis
The SPSS 22.0 software was used for descriptive and comparative statistical analysis. Histologic damage scores were presented as median AEinterquartile range and Kruskal-Wallis H test was used to calculate the significance of the data. Other values were expressed as means AE SD and analyzed by one-way ANOVA. Significant differences were defined as P value less than 0.05 (two tailed).
Results
Effect of BBR pretreatment on hepatic injury after steatotic liver transplantation
To investigate the effect of BBR on hepatic injury after steatotic liver transplantation, we initially evaluated the level of serum ALT and AST. Compared with HFD group, liver transplantation dramatically enhanced ALT and AST levels in steatotic donors, which were reduced by BBR pretreatment (P < 0.05) (Figure 2(a) and (b) ). Histological examination revealed that HFD group displayed microand macro-vesicular steatosis scattered in the liver lobule (P < 0.05). After liver transplantation, the steatotic donors displayed severe sinusoidal congestion, necrosis, inflammatory infiltration with a dramatically higher Suzuki score (P < 0.05). And a comparatively improved lobular structure and the reduced damage score were observed in steatotic grafts preconditioned with BBR (P < 0.05) ( Figure 3 ).
Effects of BBR on hepatic oxidative stress and inflammation after steatotic liver transplantation
The activation of oxidative stress and inflammation is considered to be secondary to direct cellular damage resulting from ischemic insult. Compared with HFD group, liver transplantation elevated the expression of MDA with the reduced SOD activity in steatotic grafts (P < 0.05). Pretreatment with BBR drastically suppressed the oxidative stress level in steatotic grafts after liver transplantation (P < 0.05) (Figure 2 (c) and (d)). Similarly, compared with HFD group, the production of inflammatory factors (TNF-a, IL-1b) was greatly increased in steatotic grafts after liver transplantation. Pretreatment of BBR inhibited the hepatic inflammatory reaction after steatotic liver transplantation (P < 0.05) (Figure 2 (e) and (f)).
BBR pretreatment inhibited the ER stress induced autophagy in steatotic grafts after liver transplantation
To analyze the role of ER stress-mediated autophagy in the salutary effects of BBR, the expression of ER stress parameters (p-PERK/PERK, CHOP, Bip) and autophagy-related proteins was detected using Western blotting. Figure 4 showed that the level of CHOP, Bip, and the phosphorylation of PERK was significantly increased in steatotic grafts after liver transplantation compared with HFD group, which could be down-regulated after BBR pretreatment (P < 0.05). Figure 5 showed the expression of autophagyrelated proteins in different groups. Compared with HFD group, the ratio of LC3II/I, Beclin-1, and p62 expression was concurrently increased in steatotic grafts after liver transplantation. And BBR treatment could significantly inhibit the level of autophagy, which was counteracted by ER stress inducer TG (P < 0.05).
BBR treatment inhibited the selective autophagy of ER in steatotic grafts after liver transplantation
Transmission electron microscopy revealed the accumulation of autophagosomes and the reduction of rough ER were induced in steatotic grafts after liver transplantation, which could be reversed by BBR ( Figure 6 ). Accordingly, we hypothesized that autophagy mediated the degradation of ER in steatotic grafts. To confirm the hypothesis, the co-localization of ER (KDEL) and autophagy (LC3B) was analyzed by double-immunofluorescence microscopy. In Figure 7 , the co-localization of ER and autophagy appeared weak in SD group but was gradually stronger in HFD group. Liver transplantation further enhanced the co-localization of ER and autophagy. However, BBR pretreatment reduced the ER localization with LC3B, which could be abolished by TG. FAM134B is a kind of ER-resident receptor which specifically binds to autophagy and facilitates ER degradation. In our study, LT enhanced the expression of FAM134B in steatotic livers compared with HFD group. Also, BBR preconditioning significantly impedes the level of FAM134B, which was reversed by TG (P < 0.05) (Figure 8 ). These results indicated that BBR could inhibit reticulophagy in steatotic grafts after liver transplantation. 
Discussion
Although pharmacological studies have demonstrated the therapeutic actions of BBR on hepatic steatosis or I/R injury, 22, 26 the benefits of BBR on steatotic grafts after liver transplantation remain poorly understood. Several findings in the present study help to elucidate the protective mechanism of BBR against I/R injury after steatotic liver transplantation. Firstly, BBR could ameliorate hepatic injury in steatotic livers undergoing transplantation by inhibiting the level of oxidative stress and inflammation. Secondly, this protective action might be attributed to the inhibition of ER stress-mediated reticulophagy.
A large body of studies have proved the multitude biological effects of BBR including anti-hyperglycemic, anti-tumorigenesis, and anti-hyperlipidemia activities. 18, 27, 28 Clinical evidence demonstrated that BBR treatment markedly decreased serum levels of lipid metabolites in patients with nonalcoholic fatty liver disease. 29 Our previous data documented that BBR could ameliorate I/R injury in non-steatotic grafts undergoing liver transplantation via activating Sirt1/FoxO3a pathway. 22 In the present study, BBR attenuated the pathological damage and reduced the expression of plasma liver enzymes compared with HFD þ LT group. The oxidative stress and inflammation were also inhibited at the same time. These data ER is essential for maintaining the homeostasis of intracellular calcium and lipid metabolism. Under stress conditions, the UPR would be induced or exacerbated, which augments I/R injury of multiple organs. 30, 31 In the model of myocardial I/R injury of rats, BBR inhibited ER stress via activating JAK2/STAT3 pathway. 6 ER stress also occurs in both non-steatotic and steatotic donors after liver transplantation and its magnitude is more prolonged and severe in steatotic grafts. 10 Consistent with previous literatures, liver transplantation was sufficient to activate the expression of ER stress parameters (p-PERK, CHOP, Bip) in steatotic donors, which could be inhibited by BBR pretreatment.
Under ER stress, several adaptive mechanisms including autophagy can be initiated to restore the metabolic balance. Accumulated evidences show that controlled autophagy is seen as a compensatory mechanism following ER stress, 32, 33 whereas severe or prolonged autophagy may deteriorate cellular functions and end in irreversibly damage. 34, 35 In our previous work, up-regulation of autophagy exhibited a pro-survival function after liver transplantation using non-steatotic donors. 22 Interestingly, steatotic grafts undergoing liver transplantation showed the aggravated hepatic injury along with a notable increase of autophagy. Furthermore, BBR exhibited protective effect on steatotic grafts by down-regulating the expression of LC3II/LC3I, p62, and Beclin1, which could be abolished by ER stress inducer TG. Herein, our results implicated that BBR mediated hepatic protection by inhibiting ER stress-triggered autophagy.
Among all the autophagic proteins, p62 is the first protein to recognize ubiquitinylated proteins and connect ubiquitin noncovalently during autophagy. 36 Although a large body of evidences demonstrate that p62 can be eliminated under autophagy initiation. 37, 38 However, in special cases, the activation of selective autophagy is dependent on p62 induction. Selective autophagy involves in the generation of autophagosomes targeting special organelles including mitochondria (mitophagy), ER (reticulophagy), or ribosomes (ribophagy). 39 Chi et al. 40 implicated that thyroid hormone promoted selective autophagy via enhancing p62 expression, which in turn defended against hepatotoxicity and carcinogenesis. In Parkinson's disease model, the transcription of genes encoding for p62 was increased following mitophagy induction. 41 Our current study also detected the up-regulation of p62 in steatotic grafts undergoing liver transplantation. In addition, under transmission electron microscopy, we noticed the more autophagosomes with the more severe fragmentation of ER in steatotic livers subjected to liver transplantation compared with HFD group. Accordingly, it was reasonable to postulate that reticulophagy occurred in steatotic grafts after liver transplantation.
Nonetheless, reticulophagy, the autophagic sequestration of ER fragments into autophagosomes, can occur in both yeast and mammalian cells. 42 A large proportion of proteins newly synthesized in ER fail to mature properly and need to be degraded by autophagy. The observation of ER-membrane in autophagic vacuoles under electron micrography provides the strong evidence supporting to the view. The study from Lennemann et al. 43 reported the protective effects of reticulophagy against Dengue and Zika viruses, which provided a promising molecular target for the development of anti-viral drug. However, in kidney cells exposed to quantum dots, UPR-mediated reticulophagy triggered the renal toxicity. 44 In line with the previous reports, our immunofluorescence staining assays found that the co-localization between ER tracker (KDEL) and autophagy marker (LC3B) was increased in steatotic grafts undergoing liver transplantation. Moreover, the pretreatment with BBR reduced the ER localization with LC3B, which was countered by TG. FAM134B has been proven to be the hallmark of ER-phagy which serves as the cargo receptor binding to autophagy-related proteins to facilitate ER turnover. Our initial analysis showed that FAM134B expression was markedly provoked in steatotic donors after liver transplantation. Pretreatment with BBR impeded the level of FAM134B, which could be reversed by TG. Altogether, the above results supported the therapeutic potential of BBR on steatotic grafts after liver transplantation via inhibiting ER stress-mediated reticulophagy.
Although it is the first time to report the protective mechanism of BBR against steatotic liver transplantation, there are still a number of important questions remaining unresolved and warranting further research. The regulation of reticulophagy is not simple but involved in many players. Apart from FAM134B, SEC62 and reticulon 3 have been identified as the key receptors connecting the ER with autophagosomal membrane. Our finding preliminarily confirmed the presence of reticulophagy in steatotic donors after liver transplantation; the precise functions and the interplay of these receptors remain unclear and should be elucidated by further analyses. Additionally, while we have observed the inhibition of ER stressmediated reticulophagy by BBR in steatotic grafts after liver transplantation, the deeper evaluation of molecular mechanisms using genetic engineering mice by disrupting the critical gene expression is in urgent need.
In conclusion, our findings identify that steatotic liver transplantation-mediated induction of ER stress is the upstream of reticulophagy response which results in the aggravation of hepatic injury. BBR exerts the protective effects on steatotic livers undergoing transplantation by inhibiting ER stress-mediated reticulophagy, which provides a new insight into the mechanisms underlying BBR's hepatoprotection.
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